{"id":"https://openalex.org/W4412688781","doi":"https://doi.org/10.1080/14796694.2025.2539611","title":"A Phase 1 study of the novel GCN2 kinase activator NXP800 in patients with advanced cholangiocarcinoma","display_name":"A Phase 1 study of the novel GCN2 kinase activator NXP800 in patients with advanced cholangiocarcinoma","publication_year":2025,"publication_date":"2025-07-28","ids":{"openalex":"https://openalex.org/W4412688781","doi":"https://doi.org/10.1080/14796694.2025.2539611","pmid":"https://pubmed.ncbi.nlm.nih.gov/40717483","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12407588"},"language":"en","primary_location":{"id":"doi:10.1080/14796694.2025.2539611","doi":"https://doi.org/10.1080/14796694.2025.2539611","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14796694.2025.2539611","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12407588/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087312611","display_name":"Hendrien Kuipers","orcid":"https://orcid.org/0000-0002-3284-8773","observed_orcids":["https://orcid.org/0000-0002-3284-8773"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hendrien Kuipers","raw_affiliation_strings":["Mayo Clinic","Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076758389","display_name":"Joseph J. Larson","orcid":"https://orcid.org/0000-0001-8372-0465","observed_orcids":["https://orcid.org/0000-0001-8372-0465"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph J. Larson","raw_affiliation_strings":["Mayo Clinic","Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091765092","display_name":"Caitlin B. Conboy","orcid":"https://orcid.org/0000-0001-8280-056X","observed_orcids":["https://orcid.org/0000-0001-8280-056X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caitlin B. Conboy","raw_affiliation_strings":["Mayo Clinic","Division of Medical Oncology, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Division of Medical Oncology, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064791048","display_name":"Daniel H. Ahn","orcid":"https://orcid.org/0000-0002-0161-4018","observed_orcids":["https://orcid.org/0000-0002-0161-4018"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel H. Ahn","raw_affiliation_strings":["Mayo Clinic Cancer Center","Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Cancer Center","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074891676","display_name":"Tanios Bekaii\u2010Saab","orcid":"https://orcid.org/0000-0001-7721-1699","observed_orcids":["https://orcid.org/0000-0001-7721-1699","https://orcid.org/0000-0003-4653-4537"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanios Bekaii-Saab","raw_affiliation_strings":["Mayo Clinic Cancer Center","Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Cancer Center","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046255337","display_name":"Christina Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Wu","raw_affiliation_strings":["Mayo Clinic Cancer Center","Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Cancer Center","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059366804","display_name":"Mohamad Bassam Sonbol","orcid":"https://orcid.org/0000-0002-6931-242X","observed_orcids":["https://orcid.org/0000-0002-6931-242X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohamad Bassam Sonbol","raw_affiliation_strings":["Mayo Clinic Cancer Center","Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Cancer Center","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006827585","display_name":"Sumera Irie Ilyas","orcid":"https://orcid.org/0000-0002-2709-3003","observed_orcids":["https://orcid.org/0000-0002-2709-3003"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sumera I. Ilyas","raw_affiliation_strings":["Mayo Clinic","Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110052872","display_name":"Greg J. Gores","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory J. Gores","raw_affiliation_strings":["Mayo Clinic","Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064918059","display_name":"Rory L. Smoot","orcid":"https://orcid.org/0000-0001-8543-661X","observed_orcids":["https://orcid.org/0000-0001-8543-661X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rory L. Smoot","raw_affiliation_strings":["Mayo Clinic","Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018257387","display_name":"Mitesh J. Borad","orcid":"https://orcid.org/0000-0003-2700-2658","observed_orcids":["https://orcid.org/0000-0003-2700-2658"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mitesh J. Borad","raw_affiliation_strings":["Mayo Clinic Cancer Center","Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Cancer Center","institution_ids":[]},{"raw_affiliation_string":"Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039332"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018257387"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039332"],"apc_list":null,"apc_paid":null,"fwci":3.7291,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.93401432,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":97},"biblio":{"volume":"21","issue":"21","first_page":"2723","last_page":"2730"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/integrated-stress-response","display_name":"integrated stress response","score":0.9610000252723694},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8209999799728394},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7499215602874756},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44589686393737793},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.42235827445983887},{"id":"https://openalex.org/C88045685","wikidata":"https://www.wikidata.org/wiki/Q174576","display_name":"Activator (genetics)","level":3,"score":0.41593849658966064},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40947258472442627},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37541794776916504},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10138633847236633},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0946754515171051},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06919005513191223}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001650","descriptor_name":"Bile Duct Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001650","descriptor_name":"Bile Duct Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D001650","descriptor_name":"Bile Duct Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018281","descriptor_name":"Cholangiocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018281","descriptor_name":"Cholangiocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D018281","descriptor_name":"Cholangiocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1080/14796694.2025.2539611","doi":"https://doi.org/10.1080/14796694.2025.2539611","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14796694.2025.2539611","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},{"id":"pmid:40717483","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40717483","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future oncology (London, England)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12407588","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12407588/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:12407588","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12407588/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W2015613033","https://openalex.org/W2028700227","https://openalex.org/W2061825208","https://openalex.org/W2095046027","https://openalex.org/W2115261608","https://openalex.org/W2518959324","https://openalex.org/W2603204749","https://openalex.org/W2605062205","https://openalex.org/W2736733522","https://openalex.org/W2763492611","https://openalex.org/W2779231120","https://openalex.org/W2959525851","https://openalex.org/W3010944770","https://openalex.org/W3138505417","https://openalex.org/W4211248913","https://openalex.org/W4389227529","https://openalex.org/W4392298469","https://openalex.org/W4393085297","https://openalex.org/W4393095789","https://openalex.org/W4393988268"],"related_works":["https://openalex.org/W4393095789","https://openalex.org/W4389227529","https://openalex.org/W4362541402","https://openalex.org/W2981904442","https://openalex.org/W4413356506","https://openalex.org/W4403509578","https://openalex.org/W4414802368","https://openalex.org/W4286296454","https://openalex.org/W4393085894","https://openalex.org/W4399394871"],"abstract_inverted_index":{"Cholangiocarcinoma":[0],"(CCA)":[1],"is":[2,50,146,180],"a":[3,51,86,93,120],"malignancy":[4],"associated":[5],"with":[6,43,135],"poor":[7],"clinical":[8,123],"outcomes,":[9],"primarily":[10],"due":[11],"to":[12,25,37,57,147,164],"the":[13,22,39,75,116,127,149,166],"advanced":[14,136],"stage":[15],"of":[16,74,111,119,126,143,159],"most":[17],"tumors":[18],"at":[19],"diagnosis":[20],"and":[21,28,59,106,154,173],"limited":[23],"response":[24,48,56],"systemic,":[26],"targeted,":[27],"immunotherapies.":[29],"Thus,":[30],"novel":[31,94,128],"therapeutic":[32,88],"approaches":[33],"will":[34],"be":[35],"required":[36],"improve":[38],"outcomes":[40],"for":[41],"patients":[42,134],"CCA.":[44,112,139],"The":[45,140],"integrated":[46],"stress":[47],"(ISR)":[49],"signaling":[52],"pathway":[53],"activated":[54],"in":[55,90,102,107,133],"intrinsic":[58],"extrinsic":[60],"stresses,":[61],"which":[62],"can":[63,77],"activate":[64],"kinases":[65],"including":[66],"general":[67],"control":[68],"nonderepressible":[69],"2":[70,157],"(GCN2).":[71],"Prolonged":[72],"activation":[73],"ISR":[76,84],"promote":[78],"cell":[79,104],"death":[80],"induction,":[81],"making":[82],"pharmacological":[83],"modulation":[85],"promising":[87],"strategy":[89],"cancer.":[91],"NXP800,":[92],"GCN2":[95,129],"kinase":[96,130],"activator,":[97],"has":[98],"shown":[99],"antiproliferative":[100],"activity":[101],"several":[103],"lines":[105],"patient-derived":[108],"xenograft":[109],"models":[110],"Here,":[113],"we":[114],"describe":[115],"study":[117,145],"design":[118],"Phase":[121,156],"1":[122],"trial":[124,176],"(NCT06420349)":[125],"activator":[131],"NXP800":[132],"or":[137],"metastatic":[138],"primary":[141],"objective":[142],"this":[144],"determine":[148,165],"maximum":[150],"tolerated":[151],"dose":[152,158],"(MTD)":[153],"recommended":[155],"NXP800;":[160],"secondary":[161],"objectives":[162],"are":[163],"toxicity":[167],"profile,":[168],"best":[169],"response,":[170],"overall":[171],"survival,":[172],"progression-free":[174],"survival.Clinical":[175],"registration":[177],"www.clinicaltrials.gov":[178],"identifier":[179],"NCT06420349.":[181]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-10-10T00:00:00"}